The Wessex Institute of Technology is a research and educational institute. It is located in the South of England. The main goal of the Wessex Institute is to develops a series of knowledge transfer mechanisms between industry professionals and those in the field of academics.
The Wessex Institute posts jobs regularly that fulfill a variety of roles. They look for talented and bright individuals that have the educational background required to meet the Wessex Institutes needs. They hire industry experts that become involved in the Wessex Institutes research, education, and publishing roles.
Another way to find out about job opportunities at the Wessex Institute is to attend one of the many conferences that they hold around Europe. These conferences provide an excellent opportunity to network with academics and professionals as well as those already working for the Wessex Institute.
Wessex Institute at Social Media: Facebook.com/pages/Wessex-Institute-of-Technology
Dr. Clay Siegall is a co-founder of Seattle Genetics, a scientific company doing major research and drug development for targeted cancer therapies. Siegall started the company in 1998 with his partner Mark Okada. He is passionate about finding innovative cancer treatments that can help patients live longer, higher quality lives. The company received FDA approval in 2011, or one of its first antibody drug conjugates, ADCETRIS. The company formed a partnership with Takeda Pharmaceutical Company, for distribution of the drug. It is now approved in more than 65 countries around the world.
Seattle Genetics, has entered licensing agreements for its ADC technology with Pfizer, GlaxoSmithKline and Genentech. These agreements have generated more than $350 million for the company to date. Currently there are over 20 ADCs in clinical development and trials. Siegall has been a major force in raising capital and securing public financing for the company. Seattle Genetics have their initial public offering in 2001.
Dr. Clay Siegall has always had an interest in working on cures for cancer. Prior to joining Seattle Genetics, he worked with Bristol-Myers Squibb in their research Institute, from 1991 to 1997. He worked with the National Cancer Institute and the National Institutes of Health from 1988 to 1991. He is on the Board of Directors for several companies including Alder Biopharmaceuticals. Ultragenyx Pharmaceutical and he is on the Washington Roundtable.
Dr. Siegall received his Bachelor’s Degree in zoology from the University of Maryland. He earned his pH D in Genetics from George Washington University. His mission is to improve the lives of people with cancer through new antibody-based therapies. The company’s goals are carried out with honesty and integrity and respect. They strive for scientific excellence in everything they do.
More people are realizing the importance of taking preventative measures to reduce the risk of health conditions that could potentially have an adverse effect on their quality of life.
A company such as Lifeline Screening offers preventative healthcare to people living within the United States. As a company employing a staff of expert technicians, aids and physicians, Lifeline uses the latest methods of technology to obtain the most accurate results. These methods include ultrasound, finger stick blood samples and electrocardiographs. Each method is designed to provide the results needed to assess a person’s risk for certain conditions.
People who have a family history of certain conditions such as heart disease or breast cancer could have the screening performed to determine if they are at risk and then take the necessary steps for prevention. The professional tests performed through Lifeline Screening could be used to discover a predisposition to congestive heart failure, high cholesterol, arterial fibrillation or lung cancer. These conditions are just a few of the many health screening services offered by this exceptional wellness oriented company.
As an innovative healthcare company, Lifeline Screening also offers businesses the opportunity to take advantage of their screening services through partnership programs. When working with businesses, Lifeline Screening utilizes strategies that educate, engage and empower employees. They can inform employees about the benefits of early detection through screening. The first step to prevention is the disclosure of any potential at-risk conditions. These health screenings could provide a foundation for discussion with health care providers, which could aid in the management and prevention of any potentially serious conditions. A business partnership with Lifeline could also save companies money in health care costs.